Beanes S R, Dang C, Soo C, Wang Y, Urata M, Ting K, Fonkalsrud E W, Benhaim P, Hedrick M H, Atkinson J B, Lorenz H P
Department of Surgery and Dental Research Institute, UCLA Center for the Health Sciences, 10833 Le Conte Ave, Box 951665, Los Angeles, CA 90095-1665, USA.
J Pediatr Surg. 2001 Nov;36(11):1666-71. doi: 10.1053/jpsu.2001.27946.
Transforming growth factor beta (TGF-beta) bioactivity has been implicated as a potential regulator of the transition from scarless healing to scar formation in fetal wounds. Decorin is an extracellular matrix proteoglycan that regulates TGF-beta bioactivity and assists in collagen fibrillogenesis. To determine its role in scarless repair, the authors examined decorin expression in fetal fibroblasts, skin, and wounds.
A single, full-thickness, 2-mm open wound was created on the dorsal surface of fetal rats at 16.5 days (E16) and 18.5 days (E18) gestational age (term, 21.5 days [E21]). Wounds were harvested at 24 and 72 hours (n = 12 wounds per time-point). Nonwounded fetal skin at E17, E19, and E21 was harvested for analysis of decorin expression during skin development and as controls for wounds. In addition, fetal (E14, E18) and adult dermal fibroblasts were cultured for in vitro analysis. Reduced-cycle, specific primer, reverse transcriptase polymerase chain reaction was performed to quantitate decorin expression.
Decorin expression increased rapidly with increasing gestational age in both fetal fibroblasts and skin. Expression was increased 22-fold in E18 fibroblasts (P <.002) and 300-fold in adult fibroblasts (P <.001) compared with E14 fibroblasts. In skin, expression increased 74% (P <.01) during the fetal wound healing transition period between E17 and E19. However, in E16 wounds (scarless), decorin expression decreased 59% (P <.006) at 24 hours and 45% (P <.02) at 72 hours. Decorin expression did not change in E18 (scar) wounds at 24 and 72 hours (P >.05).
Early gestation fetal fibroblasts and fetal skin express decorin at lower levels than late gestation fetal and adult fibroblasts and skin. Decorin expression is down-regulated in scarless (E16) compared with scar (E18) wounds. Thus, increased decorin expression is associated with both skin development and scar formation. Conversely, decreased decorin expression is associated with scarless repair.
转化生长因子β(TGF-β)的生物活性被认为是胎儿伤口从无瘢痕愈合向瘢痕形成转变的潜在调节因子。核心蛋白聚糖是一种细胞外基质蛋白聚糖,可调节TGF-β的生物活性并协助胶原纤维形成。为了确定其在无瘢痕修复中的作用,作者检测了核心蛋白聚糖在胎儿成纤维细胞、皮肤和伤口中的表达。
在妊娠16.5天(E16)和18.5天(E18)(足月为21.5天[E21])的胎鼠背部制造一个单一的、全层的、2毫米的开放性伤口。在24小时和72小时时采集伤口样本(每个时间点n = 12个伤口)。采集E17、E19和E21时未受伤的胎儿皮肤,用于分析皮肤发育过程中核心蛋白聚糖的表达,并作为伤口的对照。此外,培养胎儿(E14、E18)和成体真皮成纤维细胞用于体外分析。采用减循环特异性引物逆转录聚合酶链反应来定量核心蛋白聚糖的表达。
在胎儿成纤维细胞和皮肤中,核心蛋白聚糖的表达随着胎龄的增加而迅速增加。与E14成纤维细胞相比,E18成纤维细胞中的表达增加了22倍(P <.002),成体成纤维细胞中的表达增加了300倍(P <.00)。在皮肤中,在E17和E19之间的胎儿伤口愈合过渡期,表达增加了74%(P <.01)。然而,在E16伤口(无瘢痕)中,核心蛋白聚糖的表达在24小时时下降了59%(P <.006),在72小时时下降了45%(P <.02)。在E18(瘢痕)伤口中,核心蛋白聚糖的表达在24小时和72小时时没有变化(P >.05)。
妊娠早期的胎儿成纤维细胞和胎儿皮肤中核心蛋白聚糖的表达水平低于妊娠晚期的胎儿和成体成纤维细胞及皮肤。与瘢痕(E18)伤口相比,无瘢痕(E16)伤口中核心蛋白聚糖的表达下调。因此,核心蛋白聚糖表达的增加与皮肤发育和瘢痕形成均相关。相反,核心蛋白聚糖表达的降低与无瘢痕修复相关。